BBAD research is running also beyond the AD-core, and neurofilament light chain (NfL) is also an interesting candidate for an Alzheimer diagnostic panel, since it strictly results from factual axonal damage, and it is plausibly very sensitive to disease progression, albeit lacking real specificity. This evidence concerns the gene NEFL and Alzheimer disease.